VYOME HOLDINGS INC (HIND) Fundamental Analysis & Valuation

NASDAQ:HIND • US92943X1046

Current stock price

2.19 USD
-0.11 (-4.78%)
At close:
2.28 USD
+0.09 (+4.11%)
After Hours:

This HIND fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. HIND Profitability Analysis

1.1 Basic Checks

  • In the past year HIND has reported negative net income.
  • In the past year HIND has reported a negative cash flow from operations.
  • HIND had negative earnings in each of the past 5 years.
  • HIND had a negative operating cash flow in each of the past 5 years.
HIND Yearly Net Income VS EBIT VS OCF VS FCFHIND Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -166.46%, HIND is doing worse than 84.90% of the companies in the same industry.
  • With a Return On Equity value of -442.87%, HIND is not doing good in the industry: 80.73% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -166.46%
ROE -442.87%
ROIC N/A
ROA(3y)-137.83%
ROA(5y)-189.7%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HIND Yearly ROA, ROE, ROICHIND Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1K -1K 2K

1.3 Margins

  • The Gross Margin of HIND (54.41%) is better than 66.15% of its industry peers.
  • HIND's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for HIND so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.2%
GM growth 5Y13.41%
HIND Yearly Profit, Operating, Gross MarginsHIND Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. HIND Health Analysis

2.1 Basic Checks

  • HIND does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for HIND has been increased compared to 1 year ago.
  • The number of shares outstanding for HIND has been increased compared to 5 years ago.
  • There is no outstanding debt for HIND. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HIND Yearly Shares OutstandingHIND Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M 5M
HIND Yearly Total Debt VS Total AssetsHIND Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of -19.18, we must say that HIND is in the distress zone and has some risk of bankruptcy.
  • HIND has a worse Altman-Z score (-19.18) than 82.29% of its industry peers.
  • HIND has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -19.18
ROIC/WACCN/A
WACC9.13%
HIND Yearly LT Debt VS Equity VS FCFHIND Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M

2.3 Liquidity

  • HIND has a Current Ratio of 1.99. This is a normal value and indicates that HIND is financially healthy and should not expect problems in meeting its short term obligations.
  • HIND has a worse Current ratio (1.99) than 61.98% of its industry peers.
  • HIND has a Quick Ratio of 1.99. This is a normal value and indicates that HIND is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.99, HIND perfoms like the industry average, outperforming 45.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 1.99
HIND Yearly Current Assets VS Current LiabilitesHIND Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. HIND Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 95.65% over the past year.
  • The Revenue for HIND has decreased by -69.70% in the past year. This is quite bad
  • Measured over the past years, HIND shows a decrease in Revenue. The Revenue has been decreasing by -0.95% on average per year.
EPS 1Y (TTM)95.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.92%
Revenue 1Y (TTM)-69.7%
Revenue growth 3Y76.07%
Revenue growth 5Y-0.95%
Sales Q2Q%-97.98%

3.2 Future

  • The Earnings Per Share is expected to grow by 18.92% on average over the next years. This is quite good.
  • Based on estimates for the next years, HIND will show a quite strong growth in Revenue. The Revenue will grow by 13.78% on average per year.
EPS Next Y100%
EPS Next 2Y41.42%
EPS Next 3Y25.99%
EPS Next 5Y18.92%
Revenue Next Year12.24%
Revenue Next 2Y-83.28%
Revenue Next 3Y-25.99%
Revenue Next 5Y13.78%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HIND Yearly Revenue VS EstimatesHIND Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2028 5M 10M 15M
HIND Yearly EPS VS EstimatesHIND Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -5M -10M -15M -20M

More info and screens

Find the best growth stocksShow best growing peers

1

4. HIND Valuation Analysis

4.1 Price/Earnings Ratio

  • HIND reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year HIND is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HIND Price Earnings VS Forward Price EarningsHIND Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HIND Per share dataHIND EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5K -10K -15K -20K

4.3 Compensation for Growth

  • A more expensive valuation may be justified as HIND's earnings are expected to grow with 25.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y25.99%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HIND Dividend Analysis

5.1 Amount

  • HIND does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HIND Fundamentals: All Metrics, Ratios and Statistics

VYOME HOLDINGS INC

NASDAQ:HIND (4/10/2026, 8:29:00 PM)

After market: 2.28 +0.09 (+4.11%)

2.19

-0.11 (-4.78%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-18
Earnings (Next)05-18
Inst Owners2.96%
Inst Owner Change0%
Ins Owners26.79%
Ins Owner Change0%
Market Cap12.35M
Revenue(TTM)2.43M
Net Income(TTM)-10.82M
Analysts82.86
Price Target15.3 (598.63%)
Short Float %3.94%
Short Ratio0.12
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.09
P/FCF N/A
P/OCF N/A
P/B 5.06
P/tB 5.8
EV/EBITDA N/A
EPS(TTM)-20591.62
EYN/A
EPS(NY)-3.23
Fwd EYN/A
FCF(TTM)-0.66
FCFYN/A
OCF(TTM)-0.66
OCFYN/A
SpS0.43
BVpS0.43
TBVpS0.38
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -166.46%
ROE -442.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.41%
FCFM N/A
ROA(3y)-137.83%
ROA(5y)-189.7%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.2%
GM growth 5Y13.41%
F-Score3
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.99
Quick Ratio 1.99
Altman-Z -19.18
F-Score3
WACC9.13%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)95.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.92%
EPS Next Y100%
EPS Next 2Y41.42%
EPS Next 3Y25.99%
EPS Next 5Y18.92%
Revenue 1Y (TTM)-69.7%
Revenue growth 3Y76.07%
Revenue growth 5Y-0.95%
Sales Q2Q%-97.98%
Revenue Next Year12.24%
Revenue Next 2Y-83.28%
Revenue Next 3Y-25.99%
Revenue Next 5Y13.78%
EBIT growth 1Y8.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y15.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.32%
OCF growth 3YN/A
OCF growth 5YN/A

VYOME HOLDINGS INC / HIND Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for VYOME HOLDINGS INC?

ChartMill assigns a fundamental rating of 3 / 10 to HIND.


Can you provide the valuation status for VYOME HOLDINGS INC?

ChartMill assigns a valuation rating of 1 / 10 to VYOME HOLDINGS INC (HIND). This can be considered as Overvalued.


How profitable is VYOME HOLDINGS INC (HIND) stock?

VYOME HOLDINGS INC (HIND) has a profitability rating of 1 / 10.


Can you provide the financial health for HIND stock?

The financial health rating of VYOME HOLDINGS INC (HIND) is 5 / 10.


What is the expected EPS growth for VYOME HOLDINGS INC (HIND) stock?

The Earnings per Share (EPS) of VYOME HOLDINGS INC (HIND) is expected to grow by 100% in the next year.